cagrilintide phase 2 Once-weekly for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding trial Three new phase 3 REIMAGINE

Reconstituted: refrigerate at 2 to 8 degrees Celsius

The material here is a research-grade lyophilized peptide vial documented for in vitro laboratory use only, with no patient-directed preparation, prescription pathway, or dispensing workflow involved

Pro Tip: Write the puncture date directly on the vial label with a permanent marker at the moment of first use

Ryder, and A

TB-500 actin-binding affinity utilises pyrene-actin polymerisation assays, measuring fluorescence changes upon actin filament formation

Consulting with a knowledgeable healthcare provider familiar with peptide therapy ensures optimal treatment selection and monitoring